Home > Blog

3 min read

Veristat Expands Global Regulatory Expertise

Meet Daphne Smyth, Vice President, Global Head of Regulatory Affairs

READ MORE

1 min read

The Human Factor: Why Team Integration Makes or Breaks Marketing Applications

In the complex world of new drug applications (NDAs) and marketing authorization applications (MAAs), success often hinges not on technical expertise alone, but on how well teams work together. While each submission brings its own unique challenges, one...

READ MORE

1 min read

Evaluating Adaptive Trials: Do They Align with Your Study’s Goals and Requirements?

Innovative clinical trial approaches, including adaptive study designs, can play a key role in improving the efficiency of new drug development within biotech and pharma clinical research.

READ MORE

3 min read

Monthly FDA Guidance and Regulatory News Review - February 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

2 min read

Unlocking Potential: Taking a Statistics-driven Approach to Clinical Trial Planning

Clinical trials are complex, and even well-designed studies may encounter challenges in demonstrating statistical significance.

READ MORE

1 min read

Timeline Mastery: The Strategic Backbone of Marketing Application Success

In the intricate dance of preparing marketing applications, the timeline serves as a choreographer, directing countless moving parts into a cohesive submission. Understanding how to craft, manage, and adapt this essential document can mean the difference...

READ MORE

2 min read

The Right Track for Data Management Success

Data management plays a formative role in driving clinical development and supporting sponsors' success. Veristat’s flexible global data management approaches enable even the most complex clinical data challenges to be overcome quickly and successfully,...

READ MORE

4 min read

Monthly FDA Guidance and Regulatory News Review - January 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

3 min read

Multi-Regional Clinical Trials: The Latest Guidance from FDA

Planning and designing clinical trials conducted in multiple geographic or regulatory regions

READ MORE

3 min read

Monthly FDA Guidance and Regulatory News Review - December 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE